Product Code: ETC11393505 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Antihypertensives Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Antihypertensives Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Antihypertensives Market - Industry Life Cycle |
3.4 Serbia Antihypertensives Market - Porter's Five Forces |
3.5 Serbia Antihypertensives Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Antihypertensives Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Serbia Antihypertensives Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Antihypertensives Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension in Serbia |
4.2.2 Growing awareness about the importance of managing hypertension |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative treatments like lifestyle changes and alternative medicine |
5 Serbia Antihypertensives Market Trends |
6 Serbia Antihypertensives Market, By Types |
6.1 Serbia Antihypertensives Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Antihypertensives Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Serbia Antihypertensives Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.1.4 Serbia Antihypertensives Market Revenues & Volume, By Monotherapy, 2021 - 2031F |
6.2 Serbia Antihypertensives Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Serbia Antihypertensives Market Revenues & Volume, By ARBs, 2021 - 2031F |
6.2.3 Serbia Antihypertensives Market Revenues & Volume, By CCBs, 2021 - 2031F |
6.2.4 Serbia Antihypertensives Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.3 Serbia Antihypertensives Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Serbia Antihypertensives Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 Serbia Antihypertensives Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.4 Serbia Antihypertensives Market Revenues & Volume, By Hospital, 2021 - 2031F |
7 Serbia Antihypertensives Market Import-Export Trade Statistics |
7.1 Serbia Antihypertensives Market Export to Major Countries |
7.2 Serbia Antihypertensives Market Imports from Major Countries |
8 Serbia Antihypertensives Market Key Performance Indicators |
8.1 Number of prescriptions for antihypertensive drugs |
8.2 Patient adherence rate to antihypertensive medication |
8.3 Percentage of hypertensive population receiving treatment |
8.4 Average blood pressure control rate among hypertensive patients |
8.5 Number of new antihypertensive drug approvals in Serbia |
9 Serbia Antihypertensives Market - Opportunity Assessment |
9.1 Serbia Antihypertensives Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Antihypertensives Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Serbia Antihypertensives Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Antihypertensives Market - Competitive Landscape |
10.1 Serbia Antihypertensives Market Revenue Share, By Companies, 2024 |
10.2 Serbia Antihypertensives Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |